Dashboard
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.29 times
Poor long term growth as Net Sales has grown by an annual rate of 1.37% and Operating profit at -23.61% over the last 5 years
With a growth in Operating Profit of 25.15%, the company declared Very Positive results in Dec 25
Technical trend is Sideways signifying no clear price momentum
With ROCE of 6.9, it has a Attractive valuation with a 1.7 Enterprise value to Capital Employed
Majority shareholders : Promoters
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 133 Cr (Micro Cap)
32.00
44
1.14%
0.24
2.45%
1.69
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Sep-17-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemcrux Enterprises Ltd is Rated Hold by MarketsMOJO
Chemcrux Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 May 2026, providing investors with the most up-to-date view of its performance and prospects.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Aug-2026 | Source : BSENewspaper Publication of standalone and consolidated unaudited financial results for the quarter ended 30th June 2026.
Announcement under Regulation 30 (LODR)-Change in Directorate
04-Aug-2026 | Source : BSEAppointment of Ms. Zarna Pankaj Thakar (DIN: 11869662) as an Additional Director (Non-Executive Independent) w.e.f. 4th August 2026; subject to regularisation by shareholders at ensuing AGM
Board Meeting Outcome for Outcome Of Board Meeting Held On 04Th August 2026
04-Aug-2026 | Source : BSEThe Board of Directors of the Company at their meeting held today i.e. Tuesday 04th August 2026 at the Registered Office of the Company at 330 Trivia Complex Natubhai Circle Racecourse Vadodara- 390007 Gujarat; inter alia approved/ passed the following resolutions: 1. Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June 2026 for F.Y. 2026-27 along with Limited Review Report thereon as reviewed and recommended by the Audit Committee. 2. The 30th Annual General meeting of the company shall be held on Thursday 17th September 2026 at 02:00 P.M. through Video Conferencing.
Corporate Actions 
No Upcoming Board Meetings
Chemcrux Enterprises Ltd has declared 10% dividend, ex-date: 17 Sep 25
No Splits history available
Chemcrux Enterprises Ltd has announced 2:1 bonus issue, ex-date: 06 Sep 21
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sanjay Marathe (36.46%)
Prasenjit Kumar Paul (1.48%)
25.85%
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
YoY Growth in quarter ended Jun 2026 is 32.97% vs -3.57% in Jun 2025
YoY Growth in quarter ended Jun 2026 is 466.67% vs -92.74% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -1.75% vs -8.55% in Sep 2024
Growth in half year ended Sep 2025 is -87.03% vs -33.05% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 3.83% vs -9.43% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -49.06% vs -40.45% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 15.20% vs -10.78% in Mar 2025
YoY Growth in year ended Mar 2026 is -4.60% vs -53.67% in Mar 2025